378 related articles for article (PubMed ID: 15939760)
21. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
22. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
23. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
Jung BP; Jugloff DG; Zhang G; Logan R; Brown S; Eubanks JH
J Neurobiol; 2003 Apr; 55(1):86-96. PubMed ID: 12605461
[TBL] [Abstract][Full Text] [Related]
24. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation specifies chromosomal localization of MeCP2.
Nan X; Tate P; Li E; Bird A
Mol Cell Biol; 1996 Jan; 16(1):414-21. PubMed ID: 8524323
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
[TBL] [Abstract][Full Text] [Related]
28. Methyl-CpG binding proteins in the nervous system.
Fan G; Hutnick L
Cell Res; 2005 Apr; 15(4):255-61. PubMed ID: 15857580
[TBL] [Abstract][Full Text] [Related]
29. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
Klose RJ; Sarraf SA; Schmiedeberg L; McDermott SM; Stancheva I; Bird AP
Mol Cell; 2005 Sep; 19(5):667-78. PubMed ID: 16137622
[TBL] [Abstract][Full Text] [Related]
30. Dynamic changes in the epigenomic state and nuclear organization of differentiating mouse embryonic stem cells.
Kobayakawa S; Miike K; Nakao M; Abe K
Genes Cells; 2007 Apr; 12(4):447-60. PubMed ID: 17397393
[TBL] [Abstract][Full Text] [Related]
31. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family.
Nielsen AL; Ortiz JA; You J; Oulad-Abdelghani M; Khechumian R; Gansmuller A; Chambon P; Losson R
EMBO J; 1999 Nov; 18(22):6385-95. PubMed ID: 10562550
[TBL] [Abstract][Full Text] [Related]
32. Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells.
Marchi M; Guarda A; Bergo A; Landsberger N; Kilstrup-Nielsen C; Ratto GM; Costa M
Epigenetics; 2007 Sep; 2(3):187-97. PubMed ID: 17965612
[TBL] [Abstract][Full Text] [Related]
33. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain.
Kernohan KD; Jiang Y; Tremblay DC; Bonvissuto AC; Eubanks JH; Mann MR; Bérubé NG
Dev Cell; 2010 Feb; 18(2):191-202. PubMed ID: 20159591
[TBL] [Abstract][Full Text] [Related]
34. The transcriptional repressor Mecp2 regulates terminal neuronal differentiation.
Matarazzo V; Cohen D; Palmer AM; Simpson PJ; Khokhar B; Pan SJ; Ronnett GV
Mol Cell Neurosci; 2004 Sep; 27(1):44-58. PubMed ID: 15345242
[TBL] [Abstract][Full Text] [Related]
35. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells.
Fodor BD; Kubicek S; Yonezawa M; O'Sullivan RJ; Sengupta R; Perez-Burgos L; Opravil S; Mechtler K; Schotta G; Jenuwein T
Genes Dev; 2006 Jun; 20(12):1557-62. PubMed ID: 16738407
[TBL] [Abstract][Full Text] [Related]
36. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression.
Fujita N; Watanabe S; Ichimura T; Tsuruzoe S; Shinkai Y; Tachibana M; Chiba T; Nakao M
J Biol Chem; 2003 Jun; 278(26):24132-8. PubMed ID: 12711603
[TBL] [Abstract][Full Text] [Related]
37. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
Nan X; Meehan RR; Bird A
Nucleic Acids Res; 1993 Oct; 21(21):4886-92. PubMed ID: 8177735
[TBL] [Abstract][Full Text] [Related]
38. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
Nan X; Campoy FJ; Bird A
Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
[TBL] [Abstract][Full Text] [Related]
39. MeCP2 and Major Satellite Forward RNA Cooperate for Pericentric Heterochromatin Organization.
Fioriniello S; Csukonyi E; Marano D; Brancaccio A; Madonna M; Zarrillo C; Romano A; Marracino F; Matarazzo MR; D'Esposito M; Della Ragione F
Stem Cell Reports; 2020 Dec; 15(6):1317-1332. PubMed ID: 33296675
[TBL] [Abstract][Full Text] [Related]
40. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
Jiang CL; Jin SG; Pfeifer GP
J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
